Menu
 

Tuesday | Wednesday | Thursday | Friday | Saturday
TUESDAY, DECEMBER 8, 2015
8:00 am - 7:00 pm REGISTRATION - Bridge Hall  
     
 

Pre-registered attendees can obtain materials. Those who have not yet registered may do so.

 
     
12:00 pm - 1:45 pm

Career Development Forum: A Networking Session for Young Investigators – Room 214

Networking and career development opportunities for early career scientists. The session is open to early-career scientists, defined as graduate students, postdoctoral or clinical fellows, or medical students and residents, who are registered attendees of the 2015 SABCS.

Space in the workshop is limited to 220 participants; registrations will be accepted on a first-come, first-served basis and is free of charge.  You can register for this session when you register for the Symposium.

 
 12:00 pm - 12:05 pm Introduction                          
 12:05 pm - 12:35 pm Panel Discussion
John R. Benson, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UNITED KINGDOM
Matthew P. Goetz, Mayo Clinic College of Medicine, Rochester, MN
Yi Li, Baylor College of Medicine, Houston, TX
Julia Beaver, US Food and Drug Administration, Silver Springs, MD
Susan G. Hilsenbeck, Baylor College of Medicine Cancer Center, Houston, TX
Steven Shak, Genomic Health, Inc., Redwood, CA
 
  12:35 pm - 1:45 pm  Roundtables (at press time)  
  Balancing Research and Clinical Practice 1
John R. Benson, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UNITED KINGDOM 
and
Hani Sbitany, The University of California, San Francisco Medical Center, San Francisco, CA

Balancing Research and Clinical Practice 2
David R. Gius, Northwestern University, Chicago, IL

Balancing Research and Clinical Practice 3
Fatima Cardoso, Champalimaud Cancer Clinical, Libson, PORTUGAL
and
Susan M. Domchek, Abramson Cancer Center of University of Pennsylvania, Philadelphia, PA

Becoming a Successful Clinical Trialist
Powel H. Brown, University of Texas MD Anderson Cancer Center, Houston, TX

Career in Grants Administration
Brandy Heckman-Stoddard, National Cancer Institute, Bethesda, MD

Careers in Industry 1
Steve Shak, Genomic Health, Inc., Redwood, CA

Careers in Industry 2
Stefan Glück, Celgene Corporation, Summit, NJ

Careers in Translational Research
Michael P. Lisanti, University of Manchester, Manchester, UNITED KINGDOM
and
Geoffrey I. Shapiro, Dana-Farber Cancer Institute, Boston, MA

Funding Sources and Strategies
Fiona J. Gilbert, University of Cambridge School of Clinical Medicine, Cambridge, UNITED KINGDOM

Grant Writing - Basic/Translational
Gary C. Chamness, Baylor College of Medicine, Houston, TX

Grant Writing - Clinical/Translational
Matthew P. Goetz, Mayo Clinic College of Medicine, Rochester, MN
and
Mark E. Robson, Memorial Sloan Kettering Cancer Center, New York, NY

How to Choose a Mentor
Michael T. Lewis, Baylor College of Medicine Cancer Center, Houston, TX

How to Get the Most Out of Your Oncology Fellowship
Eun-Sil (Shelley) Hwang, Duke Cancer Institute, Durham, NC
and
Eleftheirous (Terry) Mamounas, UF Health Cancer Center at Orlando Health, Orlando, FL

How to Get the Most Out of Your Postdoctoral Training
Matthew J. Ellis, Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX

How to Get the Most Out of Your Predoctoral Experience
Rong Li, University of Texas Health Science Center, San Antonio, TX

Making the Transition from Fellowship to Faculty
Maximilian Diehn, Stanford University, Stanford, CA

Negotiating a Job Offer or Promotion
Luzhe Sun, University of Texas Health Science Center, San Antonio, TX

Oral Presentation Skills
Fiona MacNeill, The Royal Marsden NHS Foundation Trust, London, UNITED KINGDOM

Publication Strategies:  Quality vs. Quantity
Antonio C. Wolff, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD

Searching for a Job and Interviewing - Basic Research
Susan G. Hilsenbeck, Baylor College of Medicine Cancer Center, Houston, TX
and
Yi Li, Baylor College of Medicine, Houston, TX

Searching for a Job and Interviewing - Clinical Research
Julia Beaver, US Food and Drug Administration, Silver Spring, MD

Transitioning to a Research Position in the U.S.
Fabrice Andre, Institut Gustave Roussy, Villejuif, FRANCE
and
Reshma Jagsi, University of Michigan Health System, Ann Arbor, MI

 

 12:00 pm - 1:45 pm Special Session -  Advancing Your Career With Advocates -  Room 103B
Round table discussions with advocates and investigators (and funders) sharing best practices and successful collaborations in research and clinical settings.

Space in the session is limited to 100 participants; entrance to the session is on a first-come, first-served basis and is free of charge.
 
     
12:30 pm - 1:45 pm

Special Session -  Breast Cancer Management in Low and Middle Income Countries – Hall D

Moderator: Benjamin O. Anderson, MD

University of Washington

Seattle, WA

 Breast cancer early detection strategies in absence of screening mammography

Indraneel Mittra, MBBS, FRCS, PhD

Tata Memorial Centre

Mumbai, INDIA

Guidelines and management of advanced breast cancer in limited resource settings

Nagi S. El-Saghir, MD, FACP

American University of Beirut

Beirut, LEBANON

Breast cancer care delivery in limited resource settings - making systems work

Raul Murillo, MD, MPH
International Agency for Research on Cancer
Lyon, FRANCE 

 
     
2:00 pm - 7:00 pm

EDUCATIONAL SESSIONS - Ballrooms A & B and Hall D

Supported in part by an educational grant from Susan G. Komen®

Updates on advances in key areas and in technologies available for translational research. Many of the sessions will provide attendees with a better understanding of the background leading up to talks they will hear in the succeeding days, and some of the techniques that will be used. The presentations should also provide researchers with ideas and techniques to be considered for their own studies.

 
     
2:00 pm - 3:30 pm

Genetic Risk Prediction: Beyond BRCA 1/2 – Ballroom A

Moderator: Virginia G. Kaklamani, MD, DSc

UT Health Science Center

San Antonio, TX

Management of non-BRCA breast cancer predisposition

Mark E. Robson, MD

Memorial Sloan-Kettering Cancer Center

New York, NY

Variants of uncertain significance

Fergus J. Couch, PhD

Mayo Clinic

Rochester, MN                                   

Interpretation of genetic tests and management of patients

Susan M. Domchek, MD

University of Pennsylvania

Philadelphia, PA


Integration of Metabolism and Tumor Biology - Ballroom B

Moderator: Pothana Saikumar, PhD

UT Health Science Center

San Antonio, TX

Role of mitochondrial tumor suppressor genes and metabolism in breast cancer

David R. Gius, MD, PhD

Northwestern University Feinberg School of Medicine

Chicago, IL

A metabolic profile of triple negative breast cancer

Arun Sreekumar, PhD

Baylor College of Medicine

Houston, TX

Metabolic asymmetry in breast cancer: Implications for personalised medicine

Michael Lisanti, MD-PhD

University of Manchester

Manchester, UNITED KINGDOM


Challenges and Complications of Local Therapy  Hall D

Moderator:  John R. Benson, MA DM, MD, FRCS

Cambridge University Hospitals NHS Foundation Trust

Cambridge, UNITED KINGDOM

Surveillance of the breast after conservation surgery

Fiona J. Gilbert, MB ChB

University of Cambridge 

Cambridge, UNITED KINGDOM

Indications for nipple sparing mastectomy

Jean-Yves Petit

Istituto Europeo di Oncologia

Milan, ITALY

Post-mastectomy breast reconstruction: defining the effects of adjuvant treatment modalities on surgical outcomes 

Hani Sbitany, MD

University of California

San Francisco, CA

 
     
3:45 pm - 5:15 pm

Management of Advanced Breast Cancer (ABC) – Ballroom A

Moderator:  Fatima Cardoso, MD

Champalimaud Clinical Center

Lisbon, PORTUGAL

Introduction and ABC International Consensus Guidelines

Fatima Cardoso, MD

Champalimaud Clinical Center

Lisbon, PORTUGAL

Longitudinal strategies in ER+ disease

Maura N. Dickler, MD

Memorial Sloan-Kettering Cancer Center

New York, NY

Tailoring chemotherapy

Alistair Ring, MD, FRCP

The Royal Marsden

Sutton, UNITED KINGDOM

Regimens in HER2+ disease

Sara A. Hurvitz, MD

University of California

Los Angeles, CA


Development and Use of Molecular Biomarkers for Cancer – Ballroom B

Moderator:  Ben Ho Park, MD, PhD

Johns Hopkins University

Baltimore, MD

Predictive gene expression profiles in breast cancer, where are we?

Daniel F. Hayes, MD, FASCO

University of Michigan Comprehensive Cancer Center

Ann Arbor, MI

Circulating tumor DNA analysis for liquid biopsies: Current status and future opportunities 

Maximilian Diehn, MD, PhD

Stanford University School of Medicine

Stanford, CA

Development of molecular and genomic biomarkers: A regulatory path forward

Julia A. Beaver, MD

US Food and Drug Administration

Silver Spring, MD

Less is More: Minimizing Interventions  Hall D

Moderator:  Lisa A. Carey, MD

University of North Carolina

Chapel Hill, NC

Less is more: Minimising surgery

Fiona MacNeill, MD, FRCS

The Royal Marsden NHS Foundation Trust

London, UNITED KINGDOM

Tailoring or omitting radiotherapy in early breast cancer

Timothy J. Whelan, BSc, BM, BCh, MSc, FRCPC

Juravinski Cancer Centre

Hamilton, CANADA

Less is more: de-escalating systemic therapy for breast cancer

Hope S. Rugo, MD

University of California

San Francisco, CA

 
     
5:30 pm - 7:00 pm

Endocrine Therapy: Optimal Approaches for Pre and Postmenopausal Breast Cancer - Ballroom A

Moderator:  Matthew P. Goetz, MD

Mayo Clinic

Rochester, MN

Neoadjuvant endocrine therapy

Cynthia X. Ma, MD, PhD

Washington University

St. Louis, MO

Adjuvant hormonal therapy for premenopausal breast cancer: Considerations for ovarian function suppression and aromatase inhibitors

Matthew P. Goetz, MD

Mayo Clinic

Rochester, MN

Adjuvant endocrine therapy: Is the price of forever too high?

Polly Niravath, MD

Baylor College of Medicine

Houston, TX


Controversies in the Management of DCIS – Ballroom B

Moderator:  Seema A. Khan, MD

Northwestern Medical Group 

Chicago, IL

Drivers of premalignant lesions & DCIS
Yi Li, PhD
Baylor College of Medicine
Houston, TX

Prognostic indicators in treatment of DCIS

David M. Euhus, MD

Johns Hopkins University

Baltimore, MD

Endocrine management of premalignant lesions and DCIS

E. Shelley Hwang, MD, MPH

Duke University School of Medicine

Durham, NC

 

Metabolic Syndrome and Obesity in Breast Cancer - Hall D

Moderator:  Carlos L. Arteaga, MD

Vanderbilt-Ingram Cancer Center

Vanderbilt University

Nashville, TN

Role for IGF/Insulin signaling in breast cancer

Douglas Yee, MD

University of Minnesota

Minneapolis, MN

Role of adipokines and inflammation in breast cancer risk and progression

Christos Mantzoros, MD DSc PhD hc mult

Beth Israel Deaconess Medical Center

Boston, MA

Targeted interventions: Metformin and lifestyle change

Pamela J. Goodwin, MD, MSc

Mount Sinai Hospital

Toronto, CANADA

 

 
 
 7:30 pm - 10:00 pm OPEN SATELLITE EVENT presented by Physicians Education Resource - Marriott Rivercenter, Grand Ballroom (3rd Floor)

Working Group to Advance the Treatment of Triple-Negative Breast Cancer: Examining the Evidence and Looking to the Future
 
 
Tuesday | Wednesday | Thursday | Friday | Saturday